DNA Polymerase ι Interacts with Both the TRAF-like and UBL1-2 Domains of USP7.


Journal

Journal of molecular biology
ISSN: 1089-8638
Titre abrégé: J Mol Biol
Pays: Netherlands
ID NLM: 2985088R

Informations de publication

Date de publication:
22 01 2021
Historique:
received: 10 09 2020
revised: 20 11 2020
accepted: 30 11 2020
pubmed: 7 12 2020
medline: 27 4 2021
entrez: 6 12 2020
Statut: ppublish

Résumé

Reversible protein ubiquitination is an essential signaling mechanism within eukaryotes. Deubiquitinating enzymes are critical to this process, as they mediate removal of ubiquitin from substrate proteins. Ubiquitin-specific protease 7 (USP7) is a prominent deubiquitinating enzyme, with an extensive network of interacting partners and established roles in cell cycle activation, immune responses and DNA replication. Characterized USP7 substrates primarily interact with one of two major binding sites outside the catalytic domain. These are located on the USP7 N-terminal TRAF-like (TRAF) domain and the first and second UBL domains (UBL1-2) within the C-terminal tail. Here, we report that DNA polymerase iota (Pol ι) is a novel USP7 substrate that interacts with both TRAF and UBL1-2. Through the use of biophysical approaches and mutational analysis, we characterize both interfaces and demonstrate that bipartite binding to both USP7 domains is required for efficient Pol ι deubiquitination. Together, these data establish a new bipartite mode of USP7 substrate binding.

Identifiants

pubmed: 33279577
pii: S0022-2836(20)30657-4
doi: 10.1016/j.jmb.2020.166733
pmc: PMC7873624
mid: NIHMS1660875
pii:
doi:

Substances chimiques

Recombinant Proteins 0
DNA-Directed DNA Polymerase EC 2.7.7.7
Ubiquitin-Specific Peptidase 7 EC 3.4.19.12
DNA Polymerase iota EC 2.7.7.7
POLI protein, human EC 2.7.7.7

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, N.I.H., Intramural Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

166733

Subventions

Organisme : NIGMS NIH HHS
ID : P41 GM111135
Pays : United States
Organisme : NIGMS NIH HHS
ID : R01 GM123249
Pays : United States
Organisme : NIGMS NIH HHS
ID : R35 GM128864
Pays : United States

Informations de copyright

Published by Elsevier Ltd.

Déclaration de conflit d'intérêts

Conflict of interest The authors declare they have no conflict of interest.

Références

Mol Cell Biol. 2014 Jan;34(1):132-45
pubmed: 24190967
Cell. 2009 Jul 23;138(2):389-403
pubmed: 19615732
Annu Rev Biochem. 2009;78:363-97
pubmed: 19489724
Mol Cell. 2007 Jun 22;26(6):891-8
pubmed: 17588522
Biophys J. 2017 Apr 25;112(8):1529-1534
pubmed: 28445744
Science. 2013 Feb 15;339(6121):819-23
pubmed: 23287718
Nat Commun. 2015 May 11;6:7023
pubmed: 25960197
Nucleic Acids Res. 2011 Oct;39(19):8355-65
pubmed: 21745816
J Mol Biol. 1993 Dec 5;234(3):779-815
pubmed: 8254673
PLoS Pathog. 2015 Jun 05;11(6):e1004950
pubmed: 26046769
Proc Natl Acad Sci U S A. 2012 Mar 27;109(13):4828-33
pubmed: 22411829
Protein Cell. 2015 Nov;6(11):849-52
pubmed: 26210801
Cancer Res. 2004 Aug 15;64(16):5597-607
pubmed: 15313897
EMBO J. 2008 Nov 5;27(21):2883-95
pubmed: 18923427
Cell Rep. 2015 Sep 1;12(9):1400-6
pubmed: 26299963
Oncogene. 2015 Sep 3;34(36):4791-6
pubmed: 25435364
Cell Res. 2016 Apr;26(4):441-56
pubmed: 27012468
J Biomol NMR. 1995 Nov;6(3):277-93
pubmed: 8520220
DNA Repair (Amst). 2017 Oct;58:47-51
pubmed: 28865289
J Mol Biol. 2016 Feb 22;428(4):720-725
pubmed: 26410586
J Biol Chem. 2015 Nov 6;290(45):27332-44
pubmed: 26370087
Oncogene. 2016 Feb 25;35(8):965-76
pubmed: 25961918
Arch Biochem Biophys. 2010 Nov 15;503(2):207-12
pubmed: 20816748
PLoS Biol. 2006 Feb;4(2):e27
pubmed: 16402859
Nat Struct Mol Biol. 2006 Mar;13(3):285-91
pubmed: 16474402
Genet Med. 2019 Aug;21(8):1797-1807
pubmed: 30679821
J Biol Chem. 2003 Nov 28;278(48):47753-61
pubmed: 14506283
Sci Rep. 2019 Feb 25;9(1):2724
pubmed: 30804394
EMBO J. 2002 Nov 15;21(22):6246-56
pubmed: 12426396
Cell Cycle. 2014;13(24):3921-6
pubmed: 25483066
Mol Cell. 2011 Oct 7;44(1):147-59
pubmed: 21981925
J Mol Biol. 2010 Oct 8;402(5):825-37
pubmed: 20713061
J Biol Chem. 2015 Sep 18;290(38):22907-18
pubmed: 26224631
Proc Natl Acad Sci U S A. 2017 Apr 4;114(14):E2872-E2881
pubmed: 28325877
Cell Rep. 2015 Dec 15;13(10):2072-80
pubmed: 26673319
DNA Repair (Amst). 2019 Apr;76:30-39
pubmed: 30807924
Nucleic Acids Res. 2013 Feb 1;41(3):1649-60
pubmed: 23248005
Structure. 2016 Aug 2;24(8):1335-1345
pubmed: 27452404
Science. 2005 Dec 16;310(5755):1821-4
pubmed: 16357261
J Am Chem Soc. 2003 Feb 19;125(7):1731-7
pubmed: 12580598
Mol Cell. 2005 Apr 1;18(1):25-36
pubmed: 15808506

Auteurs

Nicholas W Ashton (NW)

Laboratory of Genomic Integrity, National Institute of Child Health and Human Development, National Institutes of Health, 9800 Medical Center Drive, Bethesda, MD 20892-3371, USA. Electronic address: nicholas.ashton@nih.gov.

Gabrielle J Valles (GJ)

Department of Molecular Biology and Biophysics, UConn Health, Farmington, CT 06030, USA. Electronic address: valles@uchc.edu.

Nancy Jaiswal (N)

Department of Molecular Biology and Biophysics, UConn Health, Farmington, CT 06030, USA. Electronic address: njaiswal@uchc.edu.

Irina Bezsonova (I)

Department of Molecular Biology and Biophysics, UConn Health, Farmington, CT 06030, USA. Electronic address: bezsonova@uchc.edu.

Roger Woodgate (R)

Laboratory of Genomic Integrity, National Institute of Child Health and Human Development, National Institutes of Health, 9800 Medical Center Drive, Bethesda, MD 20892-3371, USA. Electronic address: woodgate@nih.gov.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH